RFC
BMY.RT

Regions Financial Corp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Regions Financial Corp’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,131
Closed -$14K – 891
2020
Q4 		$14K Sell
20,131
-5,256
-21% -$11.2K ﹤0.01% 832
2020
Q3 		$58K Sell
25,387
-9,332
-27% -$26.6K ﹤0.01% 779
2020
Q2 		$124K Buy
34,719
+7,761
+29% +$28K ﹤0.01% 767
2020
Q1 		$103K Buy
+26,958
New +$88.8K ﹤0.01% 758

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Regions Financial Corp's BMY.RT Position: Q1 2021 in Review

Regions Financial Corp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 20,131 shares — an estimated $14K sold.

Regions Financial Corp first reported a position in BMY.RT in Q1 2020 and held it in 4 quarters. The position peaked at $124K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Regions Financial Corp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Regions Financial Corp sold 20,131 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $14K.
  • Regions Financial Corp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2020 and held it in 4 quarters.
  • Regions Financial Corp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $124K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Regions Financial Corp's 13F filing for Q1 2021, filed 2 Jun 2021.